[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![RandianCapital Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1665482126932815874.png) Randian Capital [@RandianCapital](/creator/twitter/RandianCapital) on x XXX followers
Created: 2025-07-24 13:25:40 UTC

Chyme seems like it could be the next recent IPO darling. Trading at a discount to many of its fintech peers like Dave.

From JPMorgan recent initiation report at overweight:

Chime shares currently trade at ~9x our NTM transaction profit estimates, slightly below what we identify to be its primary comp group (AFRM, DAVE, SOFI). 

We think there’s opportunity for shares to trade higher over time given the premium value assigned to consumer-oriented, spend-centric names like SHOP and TOST, though we take a more conservative approach near term, especially considering Chime’s lack of profitability (trades 157x our NTM EBITDA) and public market history.

$CHYM


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948374022682550767/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[fintech](/topic/fintech)
[discount](/topic/discount)
[ipo](/topic/ipo)
[$dave](/topic/$dave)
[jpmorgan chase](/topic/jpmorgan-chase)
[stocks financial services](/topic/stocks-financial-services)
[stocks banks](/topic/stocks-banks)

[Post Link](https://x.com/RandianCapital/status/1948374022682550767)